#BPXAI #Biotech #ObesityDrugs #Regeneron #ClinicalTrials #PharmaInnovation #HealthcareInnovation #LifeSciences #GLP1 #DrugDevelopment To view or add a comment, sign in Explore related topics Explore content categories
At our practice, we tailor treatment plans to each patients unique health profile, preferences, and goals
When youre in your 40s, 50s, or 60s and are experiencing bloating, cramping or a weakened immune system, it could be a sign that you need to add a probiotic to your supplement lineup
The interest is high because, as Palatins CEO noted, PDE5i non-response represents a substantial unmet need these drugs account for ~$4 billion in sales, yet up to 40% of ED patients dont respond adequately
Ante este nuevo acuerdo de distribucin, Sergio Salguero, Gerente del grupo DIHEX, ha manifestado su satisfaccin ya que con ello Dihex se coloca junto a una marca lder en el sector